Campbell & CO Investment Adviser LLC Neurocrine Biosciences Inc Transaction History
Campbell & CO Investment Adviser LLC
- $1.3 Billion
- Q3 2024
A detailed history of Campbell & CO Investment Adviser LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Campbell & CO Investment Adviser LLC holds 15,836 shares of NBIX stock, worth $2.14 Million. This represents 0.14% of its overall portfolio holdings.
Number of Shares
15,836
Previous 4,781
231.23%
Holding current value
$2.14 Million
Previous $658,000
177.05%
% of portfolio
0.14%
Previous 0.06%
Shares
12 transactions
Others Institutions Holding NBIX
# of Institutions
626Shares Held
94MCall Options Held
632KPut Options Held
621K-
Black Rock Inc. New York, NY14.2MShares$1.92 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$1.35 Billion0.02% of portfolio
-
State Street Corp Boston, MA5.15MShares$697 Million0.02% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.57MShares$349 Million0.47% of portfolio
-
Bellevue Group Ag Kuesnacht, V81.86MShares$252 Million3.62% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $13B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...